Phase 1, Open-Label, Randomized, Single-Dose, Cross-Over, Bioequivalence Study Comparing Tablets (5 And 10 Mg) And Capsules (5 And 10 Mg) Of Tofacitinib Under Fasted Conditions In Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2012
At a glance
- Drugs Tofacitinib (Primary)
- Indications Inflammatory bowel diseases; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Transplant rejection
- Focus Pharmacokinetics
- 01 Jul 2012 Actual end date (July 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2012 New trial record